Gennex Laboratories Ltd 531739.BO
₹10.89 ₹0.39 (3.71%) 1D
Last Updated: Jun 22, 12:00 AM·BSE
Invest on your own
Build your own portfolio, stock by stock.
We do it for you
Professionally managed portfolios, built and rebalanced for you.
NEW
How we screen every stock
Our halal screening & purification process in 3 minutes
Screeners
Your portfolio
Calculators
TOOL
Check any stock in seconds
Search 11,000+ tickers and see the halal verdict instantly.
Our certifications
Independent proof that every stock and portfolio meets halal standards.
METHODOLOGY
How we screen every stock
Our 5-step halal methodology, in 90 seconds.
Get help
NEW
Halal investing 101
A beginner-friendly intro to investing the halal way.
Plans by product
COMPARE
Find your plan
See every feature side-by-side and pick what fits.
Investors
INVESTORS
Invest in Musaffa
We're building the financial house for 1.9B Muslims. See the deck.
531739.BO Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: January 06, 2026
Report Source: 2026 2nd Quarter Report
Gennex Laboratories Ltd. Stock Analysis 531739.BO
India Health Care Nano Cap Report: Gennex Laboratories Ltd. engages in the manufacture of bulk drugs, intermediates and biotech products. The firm is engaged in the business of manufacturing of bulk drugs and intermediaries. The company offers products in various therapeutic categories, including expectorant (mucolyte), relaxant (skeletal muscle relaxant), antihistamines, urinary tract analgesic, antifungals called triazoles, tricyclic antidepressant, acting muscle relaxants, muscle relaxant, selective serotonin reuptake inhibitors (SSRIS), and xanthine oxidase inhibitors. Its products include Guaifenesin, Methocarbamol, Fexofenadine Hcl, Phenazopyridine Hcl, Fluconazole, Melitracen Hcl, Mephenesin, Chlorphenesin, Sertraline Hcl and Allopurinol. The firm has manufacturing facilities in India which cater to both domestic and international markets. Its international markets include Bangladesh, Bolivia, China, Colombia, Costa Rica, Cuba, Germany, Indonesia, Iran, Iraq, Israel, Jordan, Kenya, South Korea, Malaysia and Mexico.
Read More Gennex Laboratories Ltd (531739.BO) Chart
Key Statistics of Gennex Laboratories Ltd (531739.BO)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
₹10.50Volume
1.40MP/E Ratio (TTM)
14.0852 Week Range
Market Cap
2.67BAvg. Volume
661.68KDividend Yield
-Financial Metrics & Statements of Gennex Laboratories Ltd (531739.BO)
FAQ's for Gennex Laboratories Ltd (531739.BO)
- According to Musaffa’s Shariah screening methodology, Gennex Laboratories Ltd (531739.BO) is currently classified as NOT HALAL as of January 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Gennex Laboratories Ltd using these criteria to determine its compliance status.
- Muslim investors may consider investing in Gennex Laboratories Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Gennex Laboratories Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Gennex Laboratories Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Gennex Laboratories Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.